Retinopathy of prematurity epidemiology and treatment trend in a tertiary medical center in Taiwan: From 2016 to 2023.

Taiwan J Ophthalmol · 2026 · PMC13431199 · PMID 42549255

Europe PMC DOI

hedged sentences

0.0150

closest p · 0.3× alpha

0.0200

boldest claim

The sentences

an increasing trendP = 0.015actually significant

Regarding the choice of anti-VEGF drugs, bevacizumab was chosen more frequently than the other two drugs ( P < 0.01), and there was an increasing trend ( P = 0.015) for aflibercept and a surge in 2021.

also in 37,734 other papers

a decreasing trendP = 0.02actually significant

A decreasing trend was observed in the number of prematurity screenings for ROP ( P = 0.02).

also in 29,529 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.